Imprivata recorded $76 million in sales during the year ended March 31, 2014, according to NASDAQ. The IPO is expected to give the company a diluted market value of about $387 million.
More Articles on IPOs:
21st Century Oncology Launches IPO
10 Things To Know About Castlight Health’s IPO
IMS Health’s $1.3B IPO Shows Investors Recognize Value of Big Data
Register to Attend Webinar
Presenters:
James Germano, MD, Joint Reconstruction Specialist|Tim Tzimas, Innovative Sterilization Technologies
Next Up in Health IT
-
Oracle unveiled its Oracle Health Oncology EHR at the Oracle Health and Life Sciences Summit in Orlando, Fla. The cancer-specific…
-
Somerville, Mass.-based Mass General Brigham is spending more on AI than it’s getting back in a straightforward financial sense —…
-
Epic said its technology roadmap remains unchanged after CEO and founder Judy Faulkner disclosed the EHR vendor had paused most…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
